CardioAcademic

Comunidad especializada en Cardiología, con el objetivo de fomentar la educación continúa a través del trabajo y participación en conjunto.

[Antonio García-Hermoso @a_garciahermoso]

👴💪 La actividad física es clave para un envejecimiento saludable.

📢 Nueva serie de The Lancet Healthy Longevity sobre actividad física en mayores.

🏋️ Fuerza y equilibrio para preservar la autonomía y prevenir la dependencia.

🔗 https://t.co/DQHishdPow

[Women As One @WomenAs1]

What can genetics tell us about Takotsubo syndrome?

A genome-wide analysis identified two genetic variants linked to pathways involving heart function, metabolism and inflammation, offering clues to the biology behind this complex condition.

https://t.co/Nj2cxOMmyE

[JAMA @JAMA_current]

#JAMAReview: Among adults undergoing #HeartTransplant, contemporary survival is high, but long-term outcomes depend on surveillance for rejection and #cardiac allograft #vasculopathy and careful management of #immunosuppression-related complications.

🔗 https://t.co/410e7sEiuu

[Ahmed Bennis MD 🫀 @drbennisahmed]

🫀 AHA 2026 | The Trials That Matter

From ZEUS and Lp(a)HORIZON to SYNCHRONIZE-CVOT, WATCH-LV and AI-ECHO: major lessons in prevention, cardiometabolic care and AI.

What worked? What didn’t? What’s next?

👇 Key takeaways in one infographic.

#AHA26 #Cardiology #HeartFailure #AI

[European Society of Cardiology Journals @ESC_Journals]

🔬 Can in silico modelling predict the outcomes of cardiovascular trials? Discover this prospective prediction of Lp(a)HORIZON, locked before topline results #Lp(a) #EJPC ⤵️ https://t.co/NyAOmP6TxH

@escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic

[Almudena Castro Conde @almucastro01]

Yes‼️
SELECT, SUMMIT… GLP-1/GIP agonists lower hs-CRP and cut events.
🎯 Inflammation is still the right target, and blocking one cytokine downstream just isn't enough. Hit the upstream driver (adiposity, metabolic dysfunction) and inflammation comes down with it 🎯

[JACC Journals @JACCJournals]

Does early TAVR improve survival in symptomatic paradoxical low-flow, low-gradient aortic stenosis?
REBOOT-PARADOX (n=120): death 29% vs 37% on medical therapy (P=.60). Symptoms and readmissions favored TAVR; trial stopped early.
@JuMehilli

New in #JACC: https://t.co/WcsKzPpNIi

[EACVI President @EACVIPresident]

🫀 Heading to EACVI 2026 in Milan? 🇮🇹

Why not make the most of your congress experience with some hands-on learning?

The EACVI 2026 Imaging Training Hub offers a fantastic opportunity to put your knowledge into practice, learn directly from experts, and build confidence in cardiovascular imaging.

With 110 interactive sessions across three days, there’s something for everyone!

🔹 TOE Workshops – Practise your transoesophageal echocardiography skills using simulators.

🔹 Simulation Village – Experience realistic scenarios in structural heart interventions.

🔹 Practical Masterclasses – Discuss clinical cases and sharpen your imaging interpretation skills with experts.

Whether you’re interested in echocardiography, cardiac CT, CMR, or nuclear cardiology, there’s plenty to explore!

📅 3–5 December 2026
📍 Milan, Italy

Don’t forget to book your place! Spaces are limited and allocated on a first-come, first-served basis.

See you in Milan! 🇮🇹

#EACVI2026 #CVImaging #Cardiology #HandsOnLearning

@rafavidalperez @YBououdina @MSBBrandao @ydaryani @Elizabeth_antos @pfelissamburu @CharlesFauvel @alexsfelixecho @galzeranod @andgiannopmd @hrt01a @WilliamKokFaiK1 @M_Marwan_ @drahmedmohsen85 @aniela_petrescu @benayozbay @slumberbell @senguptasp @ElizabetaK10533 @MihaiTrofenciuc @C_VanDeHeyning @drozgeozden @Giulia_Vinco @VazyurVasquez

[JACC Journals @JACCJournals]

State-of-the-art review in #JACCHF: Alterations in skeletal muscle (SkM) structure & metabolism are key contributors to #Exercise intolerance in #HeartFailure. Exercise training + novel pharmacotherapies targeting SkM dysfunction are emerging to treat it.

https://t.co/gHQxt4xaG5

[Circulation @CircAHA]

Full article: https://t.co/NtVLOiJaWa
@AHAScience
Authors: @ZMotovska @MarcoGuglielmo @DLBHATTMD

[Circulation @CircAHA]

Just Published at #ScientificSessions26: Multimodality Cardiac Imaging Substudy of the DAPT-SHOCK-AMI Randomized Trial: Echocardiographic and Cardiac Magnetic Resonance Assessment of Cangrelor versus Crushed Ticagrelor in Cardiogenic Shock Complicating Acute Myocardial Infarc...\

[AHA Science @AHAScience]

Cardiovascular-kidney-metabolic (CKM) health is a major focus at #ScientificSessions26.

🎥 Science Communicator @HeartDocSadiya, MD, MSc, FAHA shares the many ways attendees can the latest science in CKM health through learning labs, symposia and focused sessions.

[AHA Science @AHAScience]

🎥 @MoradiShayan, MS, PhD, talks through some of the valuable early career programming at #ScientificSessions26, covering topics such as getting involved with the American Heart Association, strengthening grant and manuscript writing skills, and building a roadmap for future success.

[AHA Science @AHAScience]

Join us at #ScientificSessions26 for The Ups and Downs of Sex Hormones: Critical Windows for Cardiovascular Health in Girls and Women.

Join moderator Jennifer Ashton, MD, MS, FACOG, and a panel of speakers to explore key connections between hormones and cardiovascular health across the lifespan.

📅 Nov. 7 | 3:15-4:30 PM CT
📍 S105D

[AHA Science @AHAScience]

ZEUS results presented at #ScientificSessions26.

Lowering interleukin-6 levels with ziltivekimab did not lower the risk of cardiovascular events in patients with ASCVD, CKD, and cardiovascular inflammation compared to placebo.

[AHA Science @AHAScience]

Lp(a) HORIZON, presented at #ScientificSessions26 showed Pelacarsen substantially lowered lipoprotein(a) but did not reduce risk of MACE compared to placebo in patients on guideline-directed medical therapy for secondary prevention of CVD.

More from @VietHeartPA 👇

[AHA Science @AHAScience]

@MoradiShayan discusses late breaking science results from ZEUS at #ScientificSessions26.

[AHA Science @AHAScience]

STREAM Results presented at #ScientificSessions26

Statin discontinuation was noninferior to continuation for a composite of major cardiovascular events and death from any cause at 2 years.

[AHA Science @AHAScience]

@DrDamluji discusses late breaking science results from ZEUS at #ScientificSessions26.

[AHA Science @AHAScience]

@AnastasiaSMihai discusses late breaking science from OPTIMAL-STROKE at #ScientificSessions26. 🎥